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Background: The aim of this study was to examine perceived stress levels in adult 
patients with uveitis.
Patients and Methods: One hundred seventy-three adult consecutive uveitis patients 
(age range 18 to 85 years) were analyzed in a cross-sectional design for their perceived 
stress, according to the Perceived Stress Questionnaire (PSQ). Stress levels were 
classified into normal stress, moderate stress, and high stress.
Results: In the majority of uveitis patients a normal stress level (82%) within the last 2 
years was detected. In a subgroup analysis, perceived stress of the patients with active 
uveitis compared with patients with non-active uveitis was significantly higher within the 
last 2 years (n=80 active/n = 45 non-active; p = 0.005).
Conclusions: Overall 18% of the uveitis patient had raised perceived stress, similar to 
the general population but patients with active uveitis were significantly more stressed. 
Therefore, consideration of stress levels may be important in the therapy of uveitis patients.
Keywords: uveitis, stress, Perceived Stress Questionnaire, inflammatory disease, disease activity
INTRODUCTION
Vision is the most important sense in humans for obtaining environmental information. In fact, 
about 40% of our sensory input is visual and the processing of visual information occupies about 
50% of our cerebral cortex activity (1). Therefore, actual or threatened vision loss may impose a 
significant mental strain on many ophthalmological patients.
Uveitis is a major sight-threatening disease that is defined by intraocular inflammation, usually 
of autoimmune or infectious etiology. Depending on anatomic localization, uveitis is classified 
into anterior, intermediate, posterior, and panuveitis. The symptoms of uveitis may vary including 
pain, photophobia, redness, epiphora, and importantly blurred vision. Treatment consists of anti-
inflammatory or anti-infectious agents, depending on the underlying etiology. Whereas some forms 
of uveitis are self-limited, other forms can lead to complete blindness and even death if an underlying 
systemic disorder remains undetected (2).
In the uveitis service of our department of ophthalmology many uveitis patients report an 
association between stress and uveitis. They perceive stress preceding the beginning or the 
recurrence of uveitis.
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Two different aspects relationships between stress and uveitis 
should be distinguished: stress may be a risk factor for inducing 
the onset or recurrence of an episode of uveitis: and stress may be 
induced by the onset of uveitis itself.
There are only few studies that have analyzed the association 
between stress during uveitis, with inconsistent findings (3). 
Furthermore, these studies are difficult to compare, as they 
examined different aspects of stress and did not use the terms 
stress and distress in a consistent manner. On a conceptual level, 
stress needs to be differentiated from the results of the stress 
experience, which is often called distress. Stress is a phenomenon 
of daily life, while distress or anxiety or depressive symptoms 
refer to psychopathology and psychiatry. In our study, we 
investigate stress in this former sense by using the Perceived Stress 
Questionnaire (PSQ). To differentiate these aspects prospective 
studies are necessary but there are few prospective studies (4, 5). 
Four studies showed a positive relationship: in a study by Carrim 
et al. (4), a correlation between stress (from our point of view it 
is distress instead of stress) and the frequency of recurrences of 
acute anterior uveitis in susceptible persons has been described 
using the General Health Questionnaire (GHQ)—an instrument 
which assessed psychopathology and the subjective experience 
of stress—and the Social Readjustment Rating Questionnaire 
(SRRQ). In another study by Franke et al. (5) it was assumed 
that the beginning of uveitis is distress-induced and that uveitis 
causes a lower quality of life. Franke et al. (6) used the Brief 
Symptom Inventory to assess psychological distress. Others, 
have found that 57.9% of 171 patients with HLA-B27-associated 
anterior uveitis specified psychological distress as an activator for 
recurrence and 34.5% named specific life events (6).
The recurrence rate of uveitis after an earthquake in the 
Hanshin-Awaji (Kobe) area of Japan was significantly higher than 
before the earthquake (10 vs. 3%) (7). The authors suggest that 
the higher recurrence rate may be caused by stress that is based 
on the abrupt changes in living conditions after the earthquake. 
In a recent study by Berlinberg et al., using the Cohen 10-item 
Perceived Stress Scale (PSS-10), stress was higher in patients 
with uveitis but with no difference between recently active and 
controlled uveitis (8).
However, there are also a few studies that report no 
correlation between stress and uveitis. For example, one study 
found that the recurrence of idiopathic acute anterior uveitis was 
not stress-induced in their patient sample (9). The psychological 
questionnaires that were used in this study were the Holmes and 
Rahe Stressful Life Events Scale and the Spielberger State-Trait 
Anxiety Inventory (STAI). There is an overlap between the state 
and the trait anxiety subscales of STAI and stress but STAI is not 
a specific stress assessment instrument.
Another study, using the Paykel scale and symptom distress 
checklist, reported no association between stressful life events or 
psychological distress and idiopathic recurrent anterior uveitis 
(10). None of these studies measured perceived stress with 
the PSQ published by Levenstein et al. (11), and revised and 
translated into German by Fliege et al. (12, 13). Furthermore, 
neither study analyzed systematically the potential relationship 
of stress and uveitic disease activity. The PSQ is a validated and 
frequently used instrument to measure subjective stress that was 
originally designed in English and has been translated to Italian, 
German, Spanish, and Chinese, with validation in populations 
such as psychiatric inpatients and outpatients, nursing students, 
health workers, psychosomatic patients, and health adults (11–
18). Therefore, the aim of our study was to measure for the first 
time perceived stress levels in adult uveitis patients using the 
PSQ, and to examine their association with anatomic location, 
etiology, age, visual acuity, and disease activity.
PATIeNTS AND MeThODS
Between March 1 and April 30, 2015 all consecutive adult patients 
(age of 18 years or above) of a databank starting January 1 2012 
(n  = 527) and including all uveitis patients from the uveitis 
service at the Department of Ophthalmology, University Hospital 
of Cologne, Germany, with the following inclusion criteria were 
mailed by us and asked to participate in our cross-sectional, non-
randomized questionnaire-based single-center study:
 (1)  confirmed diagnosis of uni- or bilateral uveitis
 (2)  age at onset of uveitis of 18 years or above.
One hundred seventy-three patients completely filled out the 
PSQ questionnaires, giving a response rate of 32.8%.
These 173 patients were included in the present retrospective 
analysis of clinical data performed in conformance with the tenets 
of the Declaration of Helsinki and approved by our Institutional 
review board and ethics committee (study number: 14-349).
The patients had not been informed about the study during 
their original clinical treatment. Informed consent was obtained 
from all individual participants included in the study and a 
psychometric postal survey was received by these ophthalmic 
patients at one measure point.
The three age ranges (18–44, 45–64, > 65 years) were based on 
clinical practice as different uveitis forms are age dependent, as 
described before (2).
Uveitis is usually a chronic disease with active and inactive 
periods. Clinical characteristics could be determined which are 
not representative of the disease activity. For the whole sample 
(n  = 173) we have data for the clinical characteristics, for a 
subgroup data regarding the disease activity. Therefore, in a 
subgroup analysis another criterion was known clinical activity 
based on retrospective analysis of the charts of the past 2 years 
defined by the presence of cells in the anterior chamber or 
vitreous and/or retinal or choroidal inflammation (2, 17). The 
activity of uveitis (active versus inactive) of the last 4 weeks (113 
patients) and 2 years (125 patients) before the date of filling the 
questionnaire could be determined in this subgroup analysis. 
Data were available from our charts and treating physicians.
At original assessment all patients underwent a comprehensive 
ophthalmic examination, including measurement of Snellen 
uncorrected visual acuity and best spectacle-corrected visual 
acuity (BSCVA). When visual acuity was different between the 
two eyes, the better visual acuity was considered. External eye 
examination, slit-lamp biomicroscopy, Goldmann applanation 
tonometry, and dilated funduscopy were performed, as described 
previously (2, 15–17).
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Standardization of uveitis nomenclature (SUN) criteria were 
used to classify the uveitis patients according to the primary 
anatomic site of inflammation: anterior uveitis, intermediate 
uveitis, posterior uveitis, and panuveitis (19). Patients with 
intermediate uveitis and significant “spill over” of cells into the 
anterior chamber or concomitant mild anterior uveitis were 
classified as intermediate uveitis when the site of maximal 
inflammation was observed in the vitreous or in the pars 
plana. Furthermore, the time sequence of the uveitis disease 
was assessed for all patients. The onset of uveitis was described 
either as sudden or insidious. The duration of an attack of uveitis 
was documented either as limited, if it was 3 months or less 
in duration or as persistent, if it was greater than 3 months in 
duration. The course of uveitis was recorded either as acute, if the 
episode was characterized by sudden onset and limited duration; 
as recurrent, if repeated episodes were separated by periods of 
inactivity without treatment in at least 3-months duration; or as 
chronic, if there was persistent uveitis with prompt relapse in less 
than 3 months after discontinuing treatment. Morphologically, 
uveitis was classified as granulomatous, if large, “mutton-fat” 
keratic precipitates, Koeppe and/or Busacca iris nodules, and/or 
optic disk and choroidal granulomas were detected (2, 18).
Screening for Systemic Disease 
Associations
All patients were screened for systemic disease associations 
using detailed clinical history, chest x-ray, blood pressure 
measurement, urine analysis, complete blood cell count with 
differential, erythrocyte sedimentation rate, as well as serum 
analyses for angiotensin-converting enzyme (and lysozyme in 
patients on angiotensin-converting enzyme inhibitors), sIL-2R, 
lues, and borrelia, as described previously (2). Using a tailored 
approach and according to individual clinical suspicion, further 
investigations were performed, as described previously (2).
The diagnosis of specific manifestations and etiologies of 
uveitis was based on the clinical picture and on classification 
according to international criteria [referenced in (2)]. Therefore, 
patients were grouped into 1) infectious uveitis, 2) specific 
clinical entity, 3) uveitis associated with systemic disease, and 4) 
idiopathic uveitis in cases in which a specific diagnosis, either 
ocular or systemic, could not be made.
The Perceived Stress Questionnaire
The PSQ-20 is a self-rating instrument which assesses the 
subjective experience of perceived stress and the existence of 
external stressors. The questionnaire consisted of 20 questions 
(see Appendix in Data Sheet 1) asking how often the particular 
statements applied. The possible answers included: almost never 
(yield 1 point in the evaluation), sometimes (2 points), often (3 
points), and usually (4 points). Some statements indicated the 
missing of stress (e.g., “you feel calm”). The PSQ-20 values ranged 
from 0 (lowest perceived stress) to 1 (highest perceived stress), and 
included four categories: “worries,” “tension,” and “joy” represented 
internal stress, and “demands” represented external stressors (13).
Every category consisted of five statements. The first category 
(worries) comprised trouble, anxiety about the future, despair, and 
frustration. The second category (tension) included restlessness, 
fatigue, and the absence of relaxation. The third category (joy) 
asked for the favorable feelings of challenge, enjoyment, power, and 
safety. The last category (demands) explored external demands such 
as the lack of time, pressure, and overload. The positively coded 
category (joy) had to be inversed to build the PSQ score (13). We 
transformed the individual categories linear to values from 0 to 100.
We used the German translated version of the PSQ-20 (13). The 
questionnaire PSQ-20 was validated in a German population by 
Fliege et al. (12). In this version, Cronbach's alpha was not less than 
0.85 and reliability not less than 0.8 regarding overall scores. In 
our sample, Cronbach's alpha for scales worries, tension, joy, and 
demands (five items each) was 0.84, 0.85, 0.82, and 0.81, respectively 
for W4 and 0.87, 0.84, 0.84, 0.84 for J2. All values indicate good 
internal consistency and reliability of the questionnaire.
The patients received per post at the same time both versions of 
the PSQ-20: The PSQ-20 W4 and the PSQ-20 J2. The PSQ-20 W4 
(4 Wochen = 4 weeks) deals with the last 4 weeks and the PSQ-20 
J2 (2 Jahre = 2 years) deals with the last 2 years of life. As both tests 
(PSQ-20 W4 and PSQ-20 J2) are identical beside the time period 
tested, and because both tests correlated highly in our sample (r = 
.87), we decided to include only the PSQ-20 J2 in the primary 
analysis, because it covers a longer time period. Data on the PSQ-
20 W4 were included in the Supplemental Data (Tables 1S–5S).
Statistical Analyses
Commercial software (SPSS Statistics version 21.0 for Windows; 
SPSS Inc., Chicago, IL, USA)  used for all statistical analyses. 
Using mean values of PSQ-20 W4 and PSQ-20 J2 and standard 
deviation (SD) two cut-off scores to classify the perceived stress 
into three levels were determined similar to a PSQ study in a 
Swedish population: low level (≤mean + 1SD), moderate level 
(> mean + 1 SD and mean < +2 SD), and high level (> mean + 
2SD).  19 The cut-off scores were >0.6378 and < 0.8376 (PSQ-
20 W4) respectively >0.6516 and <0.8643 (PSQ-20 J2) for 
moderately increased stress levels and >0.8376 (PSQ-20 W4) 
respectively >0.8643 (PSQ-20 J2) for high stress levels.
The association of the PSQ scores with the patient demographics 
and clinical characteristics was determined using the Mann-Whitney 
U test and the Kruskal-Wallis test.
Odds ratios showing the association between risk factors 
and normal or increased (moderate and high) stress level are 
calculated with the help of generalized estimating equation 
models. Using these models, measurements of both time points 
W4 and J2 can be considered but only one odds ratio is calculated 
for each risk factor.
To explore the association between the visual acuity with the 
PSQ parameters we used the Pearson correlation.  p value of less 
than 0.05 was considered statistically significant.
ReSULTS
Patient Demographics and Clinical 
Characteristics
The anatomic location of the uveitis in our patients was anterior 
in 49%, intermediate and posterior each in 23%, and panuveitis 
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in 5% (Table 1) consistent with the distribution from other 
studies [summarized in [2]].
The etiology of the uveitis comprised infectious uveitis in 13%, 
specific clinical entity in 29%, uveitis associated with systemic 
disease in 17%, and idiopathic uveitis in 41%.
The mean age at onset of uveitis patient was 49.09 ± 15.67 years 
(range 18 to 85 years). Patients were divided into three age groups: 
18 to 44 years including 7,264 patients (42%), 45–64 years including 
64 patients (37%), and >65 years including 37 patients (21%).
The mean visual acuity was 0.85 + 0.29 (range 0.04–1.6). Ten 
percent of patients had a visual acuity of <0.1–0.4, 76% a visual 
acuity of 0.5–1.0, and 10% a visual acuity of >1.0.
Further demographic and clinical parameters including 
gender, ethnicity, laterality of ocular involvement, onset, duration 
of an attack and course of uveitis, and type of inflammation are 
summarized in Table 1.
Perceived Stress Levels in Adult Uveitis 
Patients
For the previous 2 years (J2), 82% of the uveitis patients had a 
normal level of perceived stress (PSQ-20 J2: ≤ 0.6516). Moderately 
increased levels of perceived stress (PSQ-20 J2: > 0.6516 and < 
0.8643) were found in 16% (J2). Highly increased stress levels 
were found in 2% (J2) (PSQ-20 J2 > 0.8643).
For the previous 4 weeks (W4) 82% of the uveitis patients 
had a normal level of perceived stress (PSQ-20 W4 ≤ 0.6378). 
Moderately increased levels of perceived stress (PSQ-20 W4 > 
0.6378 and < 0.8376) were found in 18% (W4). Highly increased 
stress levels were found in 1% (W4) (PSQ-20 W4 > 0.8376).
Association of Perceived Stress Levels 
With Clinical Characteristics of Uveitis
The anatomic location of uveitis (Table 2) was not significantly 
associated with worries (p = 0.667), tension (p = 0.880), joy (p = 
0.667), or demands (p = 0.050). Furthermore, there was no 
significant association of the anatomic location of uveitis with 
the overall scores of perceived stress (p = 0.549).
The etiology of uveitis (Table 3) was not significantly 
associated with worries (p = 0.776), tension (p = 0.346), joy (W4: 
p = 0.254), or demands (p = 0.345). Furthermore, there was no 
significant association of the etiology of uveitis with the overall 
scores of perceived stress (p = 0.507).
The age of uveitis patients (Table 4) was significantly positively 
associated with worries (p = 0.002, respectively) and joy (p = 
0.001), but negatively associated with tension (p = 0.003), and 
demands (p < 0.001). Furthermore, there was a significant 
negative association of the age of uveitis patients with the overall 
scores of perceived stress (p < 0.001).
TABLe 1 | Patient demographics of 173 patients with anterior, intermediate, posterior, and panuveitis.
Total Anterior uveitis Intermediate 
uveitis
Posterior uveitis Panuveitis
(n = 173) (n = 85) (n = 39) (n = 40) (n = 9)
gender
Female, n (%)
Male, n (%)
111 (64%)
62 (36%)
52 (61%)
33 (39%)
28 (72%)
11 (28%)
26 (65%)
14 (35%)
5 (56%)
4 (44%)
Age at onset (years)
Mean ± SD (range)
18–24, n (%)
25–44, n (%)
45–64, n (%)
≥65, n (%)
49 ± 16 (18–85)
8 (5%)
64 (37%)
64 (37%)
37 (21%)
50 ± 14 (22–80)
1 (1%)
29 (34%)
40 (47%)
15 (18%)
48 ± 17 (19–85)
2 (5%)
17 (44%)
10 (26%)
10 (26%)
46 ± 17 (21–84)
4 (10%)
16 (40%)
12 (30%)
8 (20%)
54 ± 19 (18–74)
1 (11%)
2 (22%)
2 (22%)
4 (44%)
ethnicity
Black, n (%)
European, n (%)
Middle East, n (%)
Mediterranean ancestry, n (%)
3 (2%)
155 (90%)
3 (2%)
12 (7%)
2 (2%)
76 (89%)
2 (2%)
5 (6%)
–
38 (97%)
–
1 (3%)
–
34 (85%)
–
6 (15%)
1 (11%)
7 (78%)
1 (11%)
–
Ocular involvement
Unilateral, n (%)
Bilateral, n (%)
75 (43%)
98 (57%)
43 (51%)
42 (49%)
10 (26%)
29 (74%)
20 (50%)
20 (50%)
2 (22%)
7 (78%)
Onset of uveitis
Sudden, n (%)
Insidious, n (%)
116 (67%)
57 (33%)
63 (74%)
22 (26%)
11 (28%)
28 (72%)
34 (85%)
6 (15%)
8 (89%)
1 (11)
Duration of an attack of uveitis
Limited†, n (%)
Persistent‡, n (%)
110 (64%)
63 (36%)
62 (73%)
23 (27%)
16 (41%)
23 (59%)
29 (73%)
11 (28%)
3 (33%)
6 (67%)
Course of uveitis
Acute§, n (%)
Recurrent$, n (%)
Chronic#, n (%)
21 (12%)
94 (54%)
58 (34%)
11 (13%)
51 (60%)
23 (27%)
2 (5%)
15 (39%)
22 (56%)
6 (15%)
25 (63%)
9 (23%)
2 (22%)
3 (33%)
4 (44%)
Type of inflammation
Granulomatous, n (%)
Non-granulomatous, n (%)
14 (8%)
159 (92%)
11 (13%)
74 (87%)
2 (5%)
37 (95%)
–
40 (100%)
1 (11%)
8 (89%)
(Continued)
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The global scores of the PSQ-20 (J2) were highest in the 18–44 
and the 45–64 years age groups. The oldest patients (>65 years) 
perceived the lowest stress.
The categories worries, tension, and demands in the PSQ-20 
J2 were lowest in the oldest patient group (>65 years). Demands 
were highest in the 18–44 years old patient group. Joy was highest 
in the oldest patient group (>65 years).
The visual acuity of uveitis patients (Table 5) was not 
significantly associated with worries (p = 0.922), tension (p  = 
0.154), and joy (p = 0.808). In contrast, visual acuity was 
TABLe 2 | Perceived Stress Questionnaire values of 173 uveitis patients in dependence of the anatomic location of inflammation.
Anterior uveitis Intermediate uveitis Posterior uveitis Panuveitis p-value
(n = 85) (n = 39) (n = 40) (n = 9)
Worries J2
Mean ± SD 37 ± 26 40 ± 24 34 ± 27 36 ± 26 0.667
Tension J2
Mean ± SD 51 ± 23 51 ± 25 49 ± 26 42 ± 34 0.880
Joy J2
Mean ± SD 51 ± 26 55 ± 25 57 ± 24 59 ± 24 0.667
Demands J2
Mean ± SD 47 ± 23 38 ± 29 39 ± 23 33 ± 24 0.050
PSQ-20 J2
Mean ± SD 0.46 ± 0.21 0.43 ± 0.22 0.41 ± 0.21 0.38 ± 0.22 0.549
SD, standard deviation.
TABLe 3 | Perceived Stress Questionnaire values of 173 uveitis patients in dependence of the etiology of uveitis.
Infectious uveitis Specific clinical entity Uveitis associated with 
systemic disease
Idiopathic uveitis p-value
(n = 23) (n = 50) (n = 29) (n = 71)
Worries J2
Mean ± SD 39 ± 29 34 ± 26 37 ± 23 38 ± 26 0.776
Tension J2
Mean ± SD 58 ± 23 47 ± 23 48 ± 20 50 ± 28 0.346
Joy J2
Mean ± SD 46 ± 21 55 ± 25 60 ± 21 53 ± 28 0.254
Demands J2
Mean ± SD 45 ± 19 45 ± 23 35 ± 27 43 ± 26 0.345
PSQ-20 J2
Mean ± SD 0.49 ± 0.18 0.43 ± 0.2 0.4 ± 0.19 0.44 ± 0.24 0.507
SD, standard deviation.
TABLe 1 | Continued
etiology of uveitis
Infectious uveitis, n (%)
Specific clinical entity, n (%)
Uveitis associated with systemic 
disease, n (%)
Idiopathic uveitis, n (%)
23 (13%)
50 (29%)
29 (17%)
71 (41%)
9 (11%)
28 (33%)
12 (14%)
36 (42%)
–
–
14 (36%)
25 (64%)
14 (35%)
21 (53%)
1 (3%)
4 (10%)
–
1 (11%)
2 (22%)
6 (67%)
Visual acuity
Mean ± SD (range)
<0.1, n (%)
0.1–0.4, n (%)
0.5–1, n (%)
>1, n (%)
0.85 ± 0.29 
(0.04–1.6)
2 (1%)
15 (9%)
132 (76%)
17 (10%)
0.86 ± 0.27 
(0.05–1.35)
1 (1%)
5 (6%)
 64 (75%)
10 (12%)
0.81 ± 0.34 (0.1–1.6)
–
7 (18%)
27 (69%)
4 (10%)
0.89 ± 0.28 
(0.04–1.6)
1 (3%)
2 (5%)
34 (85%)
2 (5%)
0.74 ± 0.34 (0.1–1.25)
–
1 (11%)
7 (78%)
1 (11%)
SD, standard deviation.
†≤ 3 months duration.
‡> 3 months duration.
§Episode characterized by sudden onset and limited duration.
$Repeated episodes separated by periods of inactivity without treatment ≥3 month in duration.
#Persistent uveitis with relapse in <3 month after discontinuing treatment.
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significantly associated with demands (p < 0.001). There was no 
significant association of visual acuity of uveitis patients with the 
overall scores of perceived stress levels (p = 0.095).
The category demand was highest in the >1.0 vision groups 
and lowest in the <0.1–0.4 vision group.
Table 6S shows odds ratios for type of uveitis, etiology, age, 
visual acuity and disease activity when comparing patients with 
normal to those with increased (moderate or high) stress level. 
Only age group shows a significant effect: the risk of increased 
stress level is significantly reduced in patients older than 65 years 
when compared to younger patients (OR=0.102; 95%CI: 0.015 – 
0.706; P=0.021).
Subgroup Analysis
In a subgroup analysis another criterion was known clinical 
activity based on retrospective analysis of the charts of the past 2 
years defined by the presence of cells in the anterior chamber or 
vitreous and/or retinal or choroidal inflammation. One hundred 
twenty-five patients fulfilled this criterion regarding the previous 
2 years (PSQ-20 J2).
The status of clinical activity (active versus inactive) of uveitis 
(Table 6) within the last 2 years was significantly associated with 
worries (related to the last 2 years: J2: p = 0.001. Furthermore, there 
was a significant association of clinical activity of uveitis in the last 
2 years with the overall scores of perceived stress (p = 0.005).
Mixed Regression Models
Detailed results of all five models are given in Tables 7–11. Overall, 
in the mixed regression models age has shown to be the most 
TABLe 6 | Perceived Stress Questionnaire values of 125 (uveitis activity J2) 
uveitis patients in dependence of the disease activity (active vs. inactive; last 2 
years).
Active J2 Inactive J2 p-value
(n = 80) (n = 45)
Worries J2
Mean ± SD 42 ± 26 26 ± 22 0.001a
Tension J2
Mean ± SD 55 ± 25 43 ± 25 0.035
Joy J2
Mean ± SD 49 ± 26 59 ± 24 0.042
Demands J2
Mean ± SD 45 ± 25 35 ± 23 0.040
PSQ-20 J2
Mean ± SD 0.48 ± 0.22 0.36 ± 0.20 0.005a
SD, standard deviation.
aSignificant after Benjamini-Hochberg correction for multiple testing.
TABLe 4 | Perceived Stress Questionnaire values of 173 uveitis patients in dependence of the age groups.
18–44 years 45–64 years ≥ 65 years p-value
(n = 72) (n = 64) (n = 37)
Worries J2
Mean ± SD 39 ± 26 41 ± 26 24 ± 21 0.002a
Tension J2
Mean ± SD 54 ± 24 53 ± 23 36 ± 25 0.003a
Joy J2
Mean ± SD 51 ± 24 49 ± 26 67 ± 24 0.001a
Demands J2
Mean ± SD 51 ± 22 46 ± 22 20 ± 20 <0.001a
PSQ-20 J2
Mean ± SD 0.48 ± 0.2 0.48 ± 0.2 0.28 ± 0.18 <0.001a
SD, standard deviation.
aSignificant after Benjamini-Hochberg correction for multiple testing.
TABLe 5 | Perceived Stress Questionnaire values of 173 uveitis patients in dependence of the visual acuity.
<0.1–0.4 0.5–1.0 >1.0 p-value
(n = 24) (n = 132) (n = 17)
Worries J2
Mean ± SD 31 ± 27 37 ± 25 41 ± 26 0.425
Tension J2
Mean ± SD 35 ± 22 52 ± 24 47 ± 28 0.019
Joy J2
Mean ± SD 61 ± 23 53 ± 26 55 ± 26 0.533
Demands J2
Mean ± SD 20 ± 17 45 ± 24 48 ± 24 <0.001a
PSQ-20 J2
Mean ± SD 0.31 ± 0.18 0.45 ± 0.21 0.45 ± 0.23 0.033
SD, standard deviation.
aSignificant after Benjamini-Hochberg correction for multiple testing.
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influential variable associated with stress, which is consistent with 
the finding in the bivariate analysis (p=0.023 (worries), p=0.031 
(tension), p=0.003 (joy), p<0.001 (demands), p<0.001 (PSQ20)). 
Disease activity had significant influence on worries (p=0.044), 
tension (p=0.006), and PSQ20 (p=0.031), which was also found 
in the bivariate analysis. However, only the multivariate analysis 
showed that tension and PSQ20 were significantly reduced when 
etiology of uveitis was specific clinical entity (tension: beta=-
17.03, p=0.012; PSQ20: beta=-12.84, p=0.023) or associated with 
systemic disease (tension: beta=-18.67, p=0.026; PSQ20: beta=-
17.66, p=0.011), in comparison to infectious uveitis. Similarly, 
joy was significantly increased when etiology was different to 
infectious uveitis (specific clinical entity: beta=16.77, p=0.012; 
associated systemic disease: beta=28.73, p=0.001; idiopathic: 
beta=14.53; p=0.046).  Another finding different to the bivariate 
analysis was the dependency of demands and PSQ20 from the 
type of uveitis. Both were significantly reduced, when the uveitis 
type was posterior, instead of anterior (demands: beta=-13.94, 
p=0.009; PSQ20: beta=-10.51, p=0.031). Additionally, demands 
was significantly reduced for the type panuveitis instead of 
anterior uveitis (beta=-19.71, p=0.029). No significant influence 
of the time point (W4 vs J2) was found in any of the models.
TABLe 7 | Regression models of the Perceived Stress Questionnaire parameter 
demands in dependence of clinical parameters.
estimate 95% CI p-value
Intercept 86,79 58.889 – 114.69 <0.001
Type: intermediate (ref. 
anterior)
−9,833 −20.346 – 0.679 0.069
Type: posterior −13,935 −24.225 – −3.645 0.009
Type: panuveitis −19,706 −37.152 – −2.26 0.029
etiology: spec. clin. ent. (ref. 
infection)
−7,855 −19.674 – 3.964 0.195
etiology: assoc. systemic 
disease
−10,169 −24.734 – 4.397 0.174
etiology: idiopathic −5,039 −17.985 – 7.906 0.447
Age −0,715 −0.991 – −0.44 <0.001
Visual acuity 5,5 −8.392 – 19.392 0.439
Activity: active (ref. inactive) 1,883 −2.854 – 6.621 0.437
Time: J2 (ref.: W4) −1,666 −4.771 – 1.44 0.295
CI, confidence interval.
TABLe 8 | Regression models of the Perceived Stress Questionnaire parameter 
joy in dependence of clinical parameters.
estimate 95% CI p-value
Intercept 1,113 −29.318 – 31.544 0,943
Type: intermediate (ref. 
anterior)
−4,469 −15.936 – 6.997 0,447
Type: posterior 10,743 −0.479 – 21.965 0,063
Type: panuveitis 7,287 −11.743 – 26.316 0,455
etiology: spec. clin. ent. (ref. 
infection)
16,776 3.881 – 29.671 0,012
etiology: assoc. systemic 
disease
28,732 12.841 – 44.623 0,001
etiology: idiopathic 14,525 0.4 – 28.651 0,046
Age 0,463 0.162 – 0.763 0,003
Visual acuity 13,248 −1.91 – 28.406 0,09
Activity: active (ref. inactive) −4,347 −9.372 – 0.677 0,092
Time: J2 (ref.: W4) 2,047 −1.228 – 5.323 0,223
CI, confidence interval.
TABLe 9 | Regression models of the Perceived Stress Questionnaire parameter 
PSQ20 in dependence of clinical parameters.
estimate 95% CI p-value
Intercept 84,01 58.355 – 109.664 <0.001
Type: intermediate (ref. 
anterior)
0,837 −8.831 – 10.505 0.866
Type: posterior −10,512 −19.971 – −1.053 0.031
Type: panuveitis −10,421 −26.465 – 5.624 0.206
etiology: spec. clin. ent. (ref. 
infection)
−12,838 −23.715 – −1.961 0.023
etiology: assoc. systemic 
disease
−17,657 −31.06 – −4.254 0.011
etiology: idiopathic −9,334 −21.25 – 2.582 0.128
Age −0,473 −0.727 – −0.22 <0.001
Visual acuity −3,989 −16.778 – 8.799 0.542
Activity: active (ref. inactive) 4,447 0.441 – 8.454 0.031
Time: J2 (ref.: W4) −1,925 −4.512 – 0.662 0.148
CI, confidence interval.
TABLe 10 | Regression models of the Perceived Stress Questionnaire parameter 
tension in dependence of clinical parameters.
estimate 95% CI p-value
Intercept 79,12 48.142 – 110.099 <0.001
Type: intermediate (ref. 
anterior)
3,677 −7.994 – 15.347 0.538
Type: posterior −6,661 −18.088 – 4.767 0.256
Type: panuveitis −4,094 −23.462 – 15.274 0.679
etiology: spec. clin. ent. (ref. 
infection)
−17,029 −30.142 – −3.917 0.012
etiology: assoc. systemic 
disease
−18,671 −34.833 – −2.51 0.026
etiology: idiopathic −10,913 −25.274 – 3.448 0.139
Age −0,342 −0.648 – −0.036 0.031
Visual acuity 0,396 −15.013 – 15.806 0.96
Activity: active (ref. inactive) 8,011 2.423 – 13.599 0.006
Time: J2 (ref.: W4) −3,19 −6.902 – 0.522 0.095
CI, confidence interval.
TABLe 11 | Regression models of the Perceived Stress Questionnaire parameter 
worries in dependence of clinical parameters.
estimate 95% CI p-value
Intercept 70,153 38.997 – 101.309 <0.001
Type: intermediate (ref. 
anterior)
5,002 −6.739 – 16.743 0.406
Type: posterior −10,187 −21.675 – 1.301 0.085
Type: panuveitis −10,813 −30.298 – 8.672 0.279
etiology: spec. clin. ent. (ref. 
infection)
−9,889 −23.098 – 3.319 0.145
etiology: assoc. systemic 
disease
−13,256 −29.532 – 3.02 0.113
etiology: idiopathic −7,025 −21.495 – 7.444 0.343
Age −0,362 −0.67 – −0.054 0.023
Visual acuity −8,567 −24.096 – 6.962 0.282
Activity: active (ref. inactive) 5,099 0.168 – 10.03 0.044
Time: J2 (ref.: W4) −1,294 −4.484 – 1.897 0.428
CI, confidence interval.
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DISCUSSION
This is the first study to analyze perceived stress levels in uveitis, 
a major sight-threatening disease, using the PSQ.
We found that perceived stress was significantly higher in 
patients with active uveitis within the last 2 years in comparison 
to patients with quiescent uveitis for at least 2 years, respectively. 
Overall 18% of the uveitis patient had raised perceived stress, 
similar to the general population but patients with active uveitis 
were significantly more stressed. Furthermore, the external 
perceived stress parameter “demands” was significantly negatively 
associated with visual acuity (defined as best-corrected sharpness 
of vision). The risk for a moderate or higher stress level however 
was not increased significantly, when the disease was active 
(OR = 1.932 but 95% CI = 0.888–4.204 and P = 0.097).
When comparing the classification of the stress levels the 
values of PSQ-20 W4 and PSQ-20 J2 were similar, indicating that 
the stress level rarely changed when comparing the last 2 years 
versus the last month.
This result could depend on a recall bias of the patients who 
could not differentiate exactly between former and acute stress.
A German study explored the perceived stress of the adult 
German general population (N = 2552) and the results show a 
prevalence rate for a moderately raised stress level (cut-off value: > 
0.45) from 14.5 and 3.1% for a high stress level (cut-off value: 0.6) 
(14, 19). Thus, 17.6% have an increased stress level. These results 
are similar to our results, when analyzing all consecutive uveitis 
patients regardless of clinical activity. When considering the 
activity of clinical disease there was a significantly higher stress 
level in patients with active inflammation within the last 2 years 
(Table 6). That suggests that in patients with quiescent disease 
the moderate stress level of uveitis patients is similar (16–18 
vs. 14.5%) to the German general population, but patients with 
active disease have a higher stress level. Lower overall stress levels 
compared to our results and the results of the German study (14, 
19), were found in a study by Bergdahl et al. who used the PSQ 
to examine the stress level of 1275 Swedish patients from the 
dental health service registers with the age ranged from 20 to 69 
years, that represented the Swedish population. In this study a 
moderate stress level occurs in 10% and high stress level in 4% 
of the population (12). These differences may be due to different 
living conditions in Sweden compared to Germany.
Furthermore, we determined a significant association between 
perceived stress and the age of uveitis patients. Perceived stress 
was higher in the age groups with patients between 18 and 44 and 
45–64 years. Lowest perceived stress occurred in the oldest age 
group ≥65 years. The odds ratio shows that the risk for increased 
stress level is reduced to about 10% in patients older than 65 
years (OR = 0.102). Similar results were reported in a German 
study on a normal population: perceived stress was highest in the 
age group from 31 to 60 years old, followed by patients from 18 to 
30 years and lowest perceived stress was found in patients over 61 
years (19). The study of Fliege et al. showed that perceived stress 
declines in patients over 60 years (13).
In our study we found significant associations between visual 
acuity and the category “demands” for both the last 4 weeks and 
the last 2 years. The patients with the best visual acuity (0.5–1.0 
and  1.0) perceived highest demands, and patients with lowest 
visual acuity (<0.1–0.4) the lowest demands. As demands 
represents the subjective perceived external stressors (e.g., 
absence of time, pressure, and congestion), this could represent 
a decrease of demands for patients with visual disability who 
sometimes may receive more social support. However, the risk 
for increased stress level was not significantly increased for 
patients with higher visual acuity.
Murphy et al. have shown that most intermediate uveitis 
patients can keep their good visual acuity and quality of life 
(20). This study showed a correlation between the vision in the 
worse eye and the impairment of the vision related quality of 
life and an association between the impairment of the general 
health related quality of life in patients with intermediate uveitis. 
However, we found no significant association between stress 
and the anatomic location and etiology of uveitis. Other studies 
involve only patients with anterior uveitis (4, 5, 7, 10) or they 
did not provide the anatomic location of the uveitis (6, 8). So we 
cannot compare our results with these other studies in relation 
to the anatomic location. Moreover, some other studies did not 
specify the etiology or they did not show comparisons to other 
etiologies in relation to the perceived stress. Yamamoto et al. 
gave information on etiology, but provide no statistical results in 
relation to the anatomic location and the association with stress 
(7). Berlinberg et al. (8) compared stress levels in patients with 
active versus inactive uveitis, defined by inflammatory activity 
within the past 90 days. In contrast to our results that included 
episodes of activity of the last 2 years, they found no difference 
between active versus controlled uveitis. This highlights the need 
for further prospective studies because one single factor such 
as disease activity could be further subdivided dependent on 
the numbers and activity grades of uveitic recurrences and the 
duration of disease and observation.
The sample of the current study is comparable with the whole 
cohort of our uveitis service (2): e.g., subtype of uveitis [53% 
for anterior, 19% for intermediate, 21% for posterior, and 7% 
for panuveitis (2) versus 49% for anterior, 23% for intermediate, 
23% for posterior, and 5% for panuveitis in the current sample of 
responders], age at onset, laterality, etiology. In the current sample 
there are 64% female patients in the responder group of the current 
sample, in the former publication there were 55% female patients.
Stress appears to play an important role for numerous diseases 
and living conditions including inflammatory bowel disease 
(21), and multiple sclerosis (22), cardiovascular disease (21) 
psychosomatic disorders, females after spontaneous abortion, 
students, and tinnitus patients (13), compared to healthy adults. 
In our sample patients with active disease had higher stress levels 
compared with non-active disease.
An interesting finding revealed by multivariate regression 
analysis was reduced tension and overall PSQ20 stress level, when 
etiology was specific clinical entity or associated with systemic 
disease as opposed to an infectious etiology. At this moment, 
we can only speculate about the significance of this difference. 
The most common infectious etiologies in our sample were 
infections with Toxoplasma gondii and herpetic viruses (herpes 
simplex, varicella zoster, and cytomegalovirus). Interestingly, in 
a recent large-scale study by Burgdorf et al. (23) infections with 
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Toxoplasma gondii and cytomegalovirus showed association with 
serious psychiatric disorders.
Other findings in the bivariate analysis such as the role of age 
as the most influential variable on stress in our sample, as well as 
the significant influence on worries, tension, and PSQ20, were 
confirmed by the mixed regression models.
A limitation of our study is indeed the cross-sectional design 
implying inclusion of different clinical stages of uveitis such 
as recent onset versus chronic disease. On the other the hand 
the mixed sample is a strength of the study which allows us to 
determine differences between the groups.
There are at least two possible causal interactions between 
stress and uveitis: stress may be a risk factor for inducing the 
onset of uveitis; or a reaction to the symptoms and limitations 
imposed by uveitis itself, such as decreased visual acuity. The 
cross-sectional design of this study means it cannot assess the 
nature of any cause-effect relationships in the correlations 
it identifies.
The follow-up assessment had a response rate of nearly a 
third of the whole clinical sample, of ophthalmic patients who 
were not informed about the study during their original clinical 
treatment. We do not know the activity level of uveitis of the non-
enrolled patients, which could introduce bias. There are some 
other potential sources of bias: i.) more stressed patients could be 
either more or less likely to complete the questionnaire. ii.) More 
stressed patients could be more likely to present with symptoms 
and thus more likely to be diagnosed as active. iii.) Uveitis 
treatment could contribute to perceived stress. For example, 
systemic treatment with corticosteroids could lead to depressive 
symptoms or altered mental states.
Treatments as a possible cause of perceived stress could 
not be adequately assessed due to the retrospective design 
of our study and the heterogeneous sample of our subgroups 
(different time points of treatment, different length of 
treatment, different dosages, different grades of uveitis, 
different specific entities).
Future research in the uveitis field should use a prospective 
design to assess possible etiological relationships between disease 
onset vs. activity and acute vs. chronic stress or if other factors 
such as infections may contribute independently and causatively 
to stress, as discussed above. For example, in the study of 
Levenstein et al. (24) short-term stress (4 Weeks) assessed with 
PSQ does not trigger exacerbation in ulcerative colitis, but long-
term perceived stress (2 Years) increases the risk of exacerbation 
over a period of months to years.
In summary, the results tentatively suggest that there is an 
association of perceived stress and uveitis depending on clinical 
activity. Patient with quiescent periods of at least 2 years did not 
differ from the general population regarding their stress levels. 
Therefore, future prospective studies should determine whether 
the patients with active and recurrent uveitis may benefit from 
therapeutic psychosomatic/behavioral interventions in addition 
to their anti-inflammatory therapy.
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